Wellington Management's Biopharma Portfolio

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.